Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only
Get Premium
DERM Journey Medical Corp
- Stocks
- Healthcare
- NASDAQ: DERM
Price (delayed)
$7.11
Market cap
$165.63M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$0.39
Enterprise value
$169.73M
Journey Medical Corporation focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company's marketed products include Qbrexza, a medicated
Highlights
The equity has surged by 66% year-on-year and by 7% since the previous quarter
The company's quick ratio rose by 11% QoQ and by 11% YoY
Journey Medical's net income has shrunk by 100% YoY but it has increased by 43% QoQ
DERM's EPS has dropped by 95% year-on-year but it is up by 46% since the previous quarter
The revenue is down by 30% year-on-year
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Website: https://journeymedicalcorp.com
Key stats
What are the main financial stats of DERM
Market
Valuations
Earnings
Shares outstanding
23.3M
Market cap
$165.63M
Enterprise value
$169.73M
Price to earnings (P/E)
N/A
Price to book (P/B)
7.63
Price to sales (P/S)
2.86
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
3.02
Revenue
$56.24M
Gross profit
$37.39M
Operating income
-$6.91M
Net income
-$8.3M
EBIT
-$5.2M
EBITDA
-$1.43M
Free cash flow
-$6.94M
Per share
Balance sheet
Liquidity
EPS
-$0.39
EPS diluted
-$0.39
Free cash flow per share
-$0.31
Book value per share
$0.93
Revenue per share
$2.49
TBVPS
$2.4
Total assets
$84.96M
Total liabilities
$63.42M
Debt
$25.17M
Equity
$21.54M
Working capital
$13.76M
Debt to equity
1.17
Current ratio
1.34
Quick ratio
0.97
Net debt/EBITDA
-2.86
Margins
Efficiency
Dividend
EBITDA margin
-2.5%
Gross margin
66.5%
Net margin
-14.8%
Operating margin
-12.3%
Return on assets
-11.3%
Return on equity
-52%
Return on invested capital
-35%
Return on capital employed
-11.6%
Return on sales
-9.2%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
DERM stock price
How has the Journey Medical stock price performed over time
Intraday
0.14%
1 week
-0.97%
1 month
-3.79%
1 year
36.47%
YTD
81.84%
QTD
-0.97%
Financial performance
How have Journey Medical's revenue and profit performed over time
Revenue
$56.24M
Gross profit
$37.39M
Operating income
-$6.91M
Net income
-$8.3M
Gross margin
66.5%
Net margin
-14.8%
The net margin has shrunk by 185% YoY but it is up by 43% QoQ
Journey Medical's operating income has shrunk by 166% YoY but it has increased by 49% QoQ
Journey Medical's net income has shrunk by 100% YoY but it has increased by 43% QoQ
DERM's operating margin is up by 50% QoQ
Price vs fundamentals
How does DERM's price correlate with its fundamentals
Growth
What is Journey Medical's growth rate over time
Valuation
What is Journey Medical stock price valuation
P/E
N/A
P/B
7.63
P/S
2.86
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
3.02
DERM's EPS has dropped by 95% year-on-year but it is up by 46% since the previous quarter
The equity has surged by 66% year-on-year and by 7% since the previous quarter
DERM's price to book (P/B) is 2.2% lower than its last 4 quarters average of 7.8
DERM's price to sales (P/S) is 59% higher than its last 4 quarters average of 1.8
The revenue is down by 30% year-on-year
Efficiency
How efficient is Journey Medical business performance
Journey Medical's return on assets has shrunk by 88% YoY but it has increased by 47% QoQ
The ROIC has soared by 68% QoQ
DERM's ROE has shrunk by 59% YoY but it has soared by 51% QoQ
DERM's return on sales has surged by 57% since the previous quarter
Dividends
What is DERM's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for DERM.
Financial health
How did Journey Medical financials performed over time
The company's total assets is 34% higher than its total liabilities
The company's total assets rose by 28% YoY and by 6% QoQ
DERM's total liabilities is up by 18% YoY and by 5% QoQ
The debt is 17% higher than the equity
The equity has surged by 66% year-on-year and by 7% since the previous quarter
The debt is up by 42% YoY but it is down by 2.1% QoQ
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.